Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
A role for the transcriptional coregulator RIP140 in the control of muscle endurance fitness
Elizabeth Pruzinsky, … , Tejvir S. Khurana, Daniel P. Kelly
Elizabeth Pruzinsky, … , Tejvir S. Khurana, Daniel P. Kelly
Published October 21, 2025
Citation Information: JCI Insight. 2025;10(22):e192376. https://doi.org/10.1172/jci.insight.192376.
View: Text | PDF
Research Article Metabolism Muscle biology

A role for the transcriptional coregulator RIP140 in the control of muscle endurance fitness

  • Text
  • PDF
Abstract

Poor skeletal muscle fitness contributes to many chronic disease states, including obesity, heart failure, primary muscle disorders, and age-related sarcopenia. Receptor-interacting protein 140 (RIP140) is a striated muscle–enriched nuclear receptor coregulator known to suppress mitochondrial oxidative capacity. To investigate the role of RIP140 in skeletal muscle, striated muscle–specific RIP140-deficient (strNrip1–/–) mice were generated and characterized. strNrip1–/– mice displayed an enhanced endurance performance phenotype. RNA-sequence (RNA-seq) analysis of glycolytic fast-twitch muscle from strNrip1–/– mice identified a broad array of differentially upregulated metabolic and structural muscle genes known to be induced by endurance training, including pathways involved in mitochondrial biogenesis and respiration, fatty acid oxidation, slow muscle fiber type, and angiogenesis. In addition, muscle RIP140 deficiency induced expansive neuromuscular junction (NMJ) remodeling. Integration of RNA-seq results with CUT&RUN analysis of strNrip1–/– myotubes identified Wnt16 as a candidate effector for the NMJ biogenesis in RIP140-deficient skeletal myotubes. We conclude that RIP140 serves as a physiological “rheostat” for a broad coordinated network of metabolic and structural genes involved in skeletal muscle fitness.

Authors

Elizabeth Pruzinsky, Kirill Batmanov, Denis M. Medeiros, Sarah M. Sulon, Brian P. Sullivan, Tomoya Sakamoto, Teresa C. Leone, Tejvir S. Khurana, Daniel P. Kelly

×

Figure 4

RIP140 regulates an array of pathways/processes known to be involved in muscle endurance.

Options: View larger image (or click on image) Download as PowerPoint
RIP140 regulates an array of pathways/processes known to be involved in ...
(A) PCA plot displaying WT control sedentary (WT_S), WT control trained (WT_TR), strNrip1–/– (strKO) sedentary (KO_S), and strNrip1–/– trained (KO_TR) groups from RNA-seq of EDL muscle (n = 3 per group). (B) Volcano plot comparing strKO trained and WT control trained differentially expressed genes (DEGs) from RNA-seq of EDL muscle. (C) Gene Ontology (GO) pathway analysis of upregulated Biological Process pathways in strKO trained EDL compared to WT control trained EDL. (D) Heatmap of upregulated DEGs at sedentary and trained conditions in strKO EDL muscle compared to corresponding WT controls. Fold change (FC) > 1.2, FDR < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts